OpenFilings

EyePoint Pharmaceuticals, Inc.

Form10-Q

Report Period2023-09-30

Date Filed2023-11-03

Time Filed15:47:12

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-Q
EX-31.1
EX-31.2
EX-32.1
EX-32.2
Filing on SEC Edgar